1-4 of 4
Daniel Argentieri
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Post-Marketing Surveillance with a Biosimilar of Rituximab (Novex®) in Argentina

Gustavo Milone, MD, Maria Penna, MD, Francisco Fernández, MD, Eduardo Spitzer, BS, BPharm, Susana Millan, MD, Pablo De Caso, MD, Luis Beligoy, MD, Daniel Argentieri, MD, Fernando Pagani, MD, Martín Alonso, MD, Guillermo Streich, MD, Nicolas Matias Kurgansky, MD, María del Carmen Ríos Part, MD, Martin Ignacio Brandt, MD, Susana Mari, MD, Roberto Gomez, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2131.
https://doi.org/10.1182/blood.V130.Suppl_1.2131.2131
Published: 2017
Journal Articles

90 y-Ibritumomab Tiuxetan Treatment for Relapsed and/or Refractory B-Cell Non- Hodgkin’S Lymphoma. Multi-Institutional Argentinian Study. An Update

Roberto Cacchione, MD, Jorge Milone, MD, Javier Bordone, MD, Elsa Nucifora, MD, Juan Dupont, MD, Guy Garay, Dardo Riveros, Alfredo Basso, MD, Silvia Rudoy, MD, Gustavo Milone, MD, Luis Palmer, MD, Daniel Argentieri, MD, Alicia Trouboul, MD, Maria Ardaiz, MD, Marcelo Iabstrebner, MD, Gonzalo Pombo, MD, Alicia Diaz, MD, Roberto Tur, MD, Carlos Chiattone, MD, Hugo Krupitzki, MD, Diana Lafalce, MD, Hugo Corradini, Mario Brown Arnold, MD, Carlos Cañellas, PHD, Marta Zerga, MD, Antonio Carrasco, MD, Fernando Bezares, MD
Journal: Blood
Blood (2008) 112 (11): 5009.
https://doi.org/10.1182/blood.V112.11.5009.5009
Published: 2008
Journal Articles

90 Y-Ibritumomab Treatment for Relapsed and/or Refractory B Cell Type Non-Hodgkin’s Lymphoma. Multiinstitutional Argentinian Study.

Roberto Cacchione, MD, Juan Dupont, MD, Jorge Milone, MD, Javier Bordone, MD, Guy Garay, MD, Maria Ardaiz, MD, Miguel Castro-Rios, MD, Virginia Prates, MD, Alfredo Basso, MD, Marcelo Iabstrebner, MD, Graciela Avila, MD, Alicia Diaz, MD, Daniel Argentieri, MD, Silvia Rudoy, MD, Alicia Trouboul, MD, Luis Palmer, MD, Gonzalo Pombo, MD, Silvina Rappaciotti, MD, Pedro Negri, MD, Diana Lafalse, MD, Leandro Riera, MD, Miguel de Tezanos-Pinto, MD, Dardo Riveros, MD, Mario Brown Arnold, MD, Antonio Carrasco, MD, Fernando Bezares, MD
Journal: Blood
Blood (2007) 110 (11): 4484.
https://doi.org/10.1182/blood.V110.11.4484.4484
Published: 2007
Journal Articles

Subcutaneous Alemtuzumab in Patients with Refractory/Relapsed B-Cell CLL after a Fludarabine-Based Regimen. An Interim Analysis.

R. Fernando Bezares, German Stemmelin, Daniel Argentieri, Emilio Lanari, Efrain Guy-Garay, Reinaldo Campestri, Miguel Bartomioli, Juan Jose Garcia, Sergio Giralt, Gustav Milone, on Behalf of the Latin American Cooperative Onco-Hematology Group (LACOHG)
Journal: Blood
Blood (2006) 108 (11): 2843.
https://doi.org/10.1182/blood.V108.11.2843.2843
Published: 2006